Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 26.71% vs 6.91% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 107.17% vs 81.96% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 49.79% vs 51.89% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -47.08% vs 31.21% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Astellas Pharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 19.15% vs -5.83% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 26.71% vs 6.91% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 224.99% vs -56.52% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 107.17% vs 81.96% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 83.78% vs -26.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 49.79% vs 51.89% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 2.83% vs 24.08% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -47.08% vs 31.21% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






